These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7034033)

  • 1. Effect of metergoline on the diurnal prolactin responses to insulin-induced hypoglycemia in normal men.
    Nathan RS; Sachar EJ; Tabrizi MA; Halbreich U; Asnis GM; Halpern FS
    Psychoneuroendocrinology; 1981 Dec; 6(4):365-8. PubMed ID: 7034033
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cyproheptadine and atropine on the diurnal prolactin responses to insulin-induced hypoglycemia in normal men.
    Nathan RS; Tabrizi MA; Halpern FS; Sachar EJ
    J Clin Endocrinol Metab; 1980 Jul; 51(1):90-2. PubMed ID: 6991520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metergoline, naloxone, and sodium valproate did not modify arginine vasopressin response to insulin-induced hypoglycemia in man.
    Chiodera P; Gnudi A; Volpi R; d'Amato L; Marchesi C; Pioli G; Muzzetto P; Castelli A; Bianconi L; Minelli R
    J Endocrinol Invest; 1988 May; 11(5):365-9. PubMed ID: 2846678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of metergoline to affect the circadian periodicity of plasma cortisol levels in healthy man.
    Degli Uberti E; Trasforini G; Margutti A; Rotola C; Lo Vecchio G
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):367-73. PubMed ID: 7236416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG
    Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metergoline abolishes the prolactin response to buspirone.
    Gregory CA; Anderson IM; Cowen PJ
    Psychopharmacology (Berl); 1990; 100(2):283-4. PubMed ID: 2305017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of metergoline in suppressing prolactin release induced by mechanical breast emptying.
    Delitala G; Lodico G; Masala A; Alagna S; Devilla L
    J Clin Endocrinol Metab; 1977 Apr; 44(4):763-5. PubMed ID: 849985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of metergoline on serum levels of prolactin and gonadotropin in women].
    Okura T; Hosoya N; Kitazawa M; Niibe T; Mori T
    Horumon To Rinsho; 1982 Oct; 30(10):1043-7. PubMed ID: 6819905
    [No Abstract]   [Full Text] [Related]  

  • 9. Metergoline inhibition of cimetidine-induced hyperprolactinemia.
    Lo Cascio V; Angelini G; Galyanini G; Bovo P; Ferrari M; Vaona B; Cominacini L; Cavallini G
    Horm Metab Res; 1980 Mar; 12(3):130-1. PubMed ID: 7372272
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of metergoline on serum prolactin stimulated by TRH.
    Iannotta F; Gadaleta G; Pollini C; Vettaro MP
    J Endocrinol Invest; 1980; 3(3):301-3. PubMed ID: 6776182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Diabetologia; 1975 Apr; 11(2):165-7. PubMed ID: 1149950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the induction of ovulation by metergoline in women with normoprolactinemic anovulation].
    Ohkura T; Hosoya N; Kitazawa M; Niibe T; Masaoka K; Kumasaka T
    Nihon Naibunpi Gakkai Zasshi; 1983 May; 59(5):756-73. PubMed ID: 6413262
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prolactin and ovarian function. Synthetic review and clinico-experimental research on an antiprolactin antiserotonin agent].
    Rendina M; Donadio C; Martore GB
    Patol Clin Ostet Ginecol; 1978; 6(4):196-207. PubMed ID: 680332
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
    Cocchi D; Locatelli V; Carminati R; Müller EE
    Life Sci; 1978 Sep; 23(9):927-36. PubMed ID: 703523
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 20. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.